Patent Yard Sign in
Expired European patentEurope

Use of non-peptidic bradykinin antagonists in the preparation of medicaments for the treatment and prevention of Alzheimer's disease

EP 0835659 B1 · Applicant: Aventis Pharma Deutschland GmbH

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 13, 1997 and granted December 15, 2004. A European patent lasts at most 20 years from filing, so its term ended October 13, 2017.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by April 13, 2023.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledOctober 13, 1997
PublishedApril 15, 1998
GrantedDecember 15, 2004
Term endedOctober 13, 2017
Application numberEP 97117677
Classification (CPC)A61K31/47 +2 more

Timeline

Timeline From EPO dates

1998200020022004200620082010201220142016Application filedOct 13, 1997PublishedApril 15, 1998Patent grantedDec 15, 2004Term endedOct 13, 2017

Sources & verification